{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-042017","form_type":"8-K/A","ticker":"APUS","cik":"0001894525","company_name":"Apimeds Pharmaceuticals US, Inc.","filed_at":"2026-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.249767+00:00","generated_at":"2026-05-15T06:49:38.356106+00:00","sec_items":["5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Apimeds: Majority stockholder consent to remove directors/officers is null and void","bullets":["Inscobee Inc. and Apimeds, Inc. attempted written consent to remove directors Kogan, Koo, O’Donnell, Weintraub and officers Menon (CEO) and Frim (CFO).","Company determined consent invalid due to violations of irrevocable proxy, consent waiver, and anti-frustration covenant in Support Agreement.","Support Agreement expressly states any action taken in violation is null and void; consent void ab initio.","Company will proceed with actions described in Schedule 14C Information Statement filed Feb 27, 2026, mailed March 5, 2026.","This Amendment No. 1 clarifies the previously reported actions are of no force or effect."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-042017","json":"https://secwatch.observer/filing/0001213900-26-042017.json","markdown":"https://secwatch.observer/filing/0001213900-26-042017.md","text":"https://secwatch.observer/filing/0001213900-26-042017.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026042017/0001213900-26-042017-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1894525/000121390026042017/ea0285032-8ka425_apimeds.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T06:49:38.356106+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}